Results 301 to 310 of about 133,046 (390)
We performed a survey on lifestyle habits aimed at reducing the risks associated with immunosuppression in kidney transplant recipients. We found gaps in dental hygiene, sunscreen use, vaccination, and consumption of high‐risk foods. Cultural and economic factors influenced adherence.
Tamara Ruiz‐Merlo+11 more
wiley +1 more source
Analysis of the risk of oncological adverse events associated with infliximab in combination with azathioprine compared to monotherapy: insights from the FAERS database. [PDF]
Qiao Q+9 more
europepmc +1 more source
Alternative Immunosuppression in Acquired Haemophilia A
Haemophilia, EarlyView.
Jayna Mistry+3 more
wiley +1 more source
The first live term birth following uterus transplantation in Australia
Abstract Objective To report the first live birth following uterus transplantation in Australia. Study design Case report. Setting, participant The first participant in the uterus transplantation research study program at the Royal Hospital for Women, the Prince of Wales Hospital, and Westmead Hospital in Sydney.
Rebecca Deans+21 more
wiley +1 more source
From door to diagnosis: A case report of a rare and life-threatening presentation of Takayasu arteritis. [PDF]
Habib E+11 more
europepmc +1 more source
ABSTRACT Glucose‐6‐phosphate‐dehydrogenase (G6PD) deficiency is a heterogenous disorder that may lead to severe hemolytic events with the ingestion of fava beans and exposure to certain drugs. We report the first case of a 65‐year‐old male with Crohn's disease who developed a hemolytic crisis leading to hospitalization shortly after commencement of ...
Laura Patanè+5 more
wiley +1 more source
A seven-year electroretinography follow-up of a patient with melanoma-associated retinopathy stabilized on pembrolizumab treatment. [PDF]
Tshuva-Bitton R+5 more
europepmc +1 more source
Abstract Autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) result from immune self‐tolerance loss, causing tissue damage. Standard treatments targeting late‐stage inflammation often have serious side effects. Artemisinin, known for its antimalarial properties, shows potential immunomodulatory effects.
Fanchao Zhou+4 more
wiley +1 more source